treatment-response

Documents about treatment-response

• FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder#918449ClinicalTrials.gov
• Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut#970053ClinicalTrials.gov
• Predictors of Clinical Response After Interlaminar Cervical Epidural Steroid Injection for Cervical Radiculopathy#980764ClinicalTrials.gov
• Agomelatine as augmentation therapy with second-generation antipsychotics for negative symptoms of schizophrenia: An open-label randomised clinical trial and electroencephalogram-derived model for treatment response prediction.#1001215NCBI PubMed Central
• A Perspective Study of the Antiviral Efficacy and Safety of Switching to TAF Treatment in CHB Adults With Suboptimal Response (SOR) and Intolerant to Entecavir#1033500ClinicalTrials.gov
• Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies#1047716ClinicalTrials.gov
• Pretreatment 18F-FDG PET/CT Radiomics for Predicting Response to First-Line Targeted Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma#1046204ClinicalTrials.gov
• Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers#992375ClinicalTrials.gov
• Longitudinal and stability-aware analysis reveals treatment-specific microRNA response signatures following immune-reconstitution and B-cell-targeted therapies in multiple sclerosis#161723Unpaywall
• Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study#355445Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Leveraging Policy Changes Made in Response to COVID-19 to Advance Telehealth and Novel Treatment Approaches for People Who Use Opioids: Qualitative Perspectives From Two Rural North Carolina Counties.#371649NCBI PubMed Central
• Radiographic indicators of disease severity and treatment response in medication-related osteonecrosis of the jaw: A retrospective cone-beam computed tomography-based study using an expanded composite radiographic index#622683AVESIS
• 3T MRI Biomarkers of Glioma Treatment Response#825367ClinicalTrials.gov
• Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents#828063ClinicalTrials.gov
• Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma#840974ClinicalTrials.gov
• SMART ERP for the Behavioral Treatment of Youth With Obsessive Compulsive Disorder (OCD)#849060ClinicalTrials.gov
• Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan#905597ClinicalTrials.gov
• Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study#907300ClinicalTrials.gov
• Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients#1010322ClinicalTrials.gov
• Brain Region-Specific Gene Expression Changes Following Social Isolation, Oxytocin Treatment, and Acute Stress, in Prairie Voles (Microtus ochrogaster)#168579Bucknell Digital Commons
• PCO-nAMD: Paired CFP and OCT Dataset for Neovascular Age-Related Macular Degeneration#642759Figshare
• Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response#845838ClinicalTrials.gov
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)#851798ClinicalTrials.gov
• Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment#860661ClinicalTrials.gov
• Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)#1044666ClinicalTrials.gov
• Chronic Inflammatory Disease, Lifestyle and Treatment Response#812978ClinicalTrials.gov
• Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment#877824ClinicalTrials.gov
• Study to Evaluate the Response to Treatment With Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma (FL) After at Least Two Lines of Therapy, Within the Compassionate Use Program (CUP).#887610ClinicalTrials.gov
• Biomarker Development for Autoimmune Disorders Involving the Kidneys#914527ClinicalTrials.gov
• Developing a Human Cerebral Organoid Epilepsy Model for Studying Live 4D Mitochondrial Dynamics in Response to Ketogenic Diet Treatment#983536eScholarship
• The role of self-efficacy and control beliefs in response to a multimodal headache intervention: results from a prospective observational study with a waiting-list comparator#120123Europe PMC
• Targeted Proteomics upon Treatment with Tofersen Identifies Novel Response Markers for Superoxide Dismutase 1‐Linked Amyotrophic Lateral Sclerosis#465435Open Access LMU
• S228. TOWARD EARLY DETECTION OF TREATMENT RESISTANT SCHIZOPHRENIA: PREDICTIVE INFORMATION ON NON-RESPONSE TO ANTIPSYCHOTICS BY EVALUATION OF A FEW CLINICAL FACTORS: A STUDY BY ROC CURVE ANALYSIS AND CONFIRMATORY MULTIVARIATE ANALYSIS#685228IRIS
• RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis#800528ClinicalTrials.gov
• Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)#830834ClinicalTrials.gov
• An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy#852565ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Response Duration and Safety of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU)/Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite Antihistamine Treatment (H1)#861589ClinicalTrials.gov
• Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment#881870ClinicalTrials.gov
• HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)#891503ClinicalTrials.gov
• PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer#995183ClinicalTrials.gov
• Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3#887881ClinicalTrials.gov
• Predictive factors for severity and poor treatment response in children with Evans syndrome: A retrospective cohort study#280383HAL (France)
• Do subjective and objective baseline sleep disturbances predict post-traumatic stress disorder treatment response? A secondary analysis of a randomized controlled trial.#285547PubMed
• Electrical Status Epilepticus in Sleep: Response of Neuropsychological Deficits and Epileptiform Activity to Clobazam Treatment#833972ClinicalTrials.gov
• Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment#841498ClinicalTrials.gov
• A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection#861937ClinicalTrials.gov
• Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis#870504ClinicalTrials.gov
• Mutations in the Epidermal Growth Factor Receptor(EGFR) Gene in Non-Small Cell Lung Carcinoma (NSCLC) and the Relation to Response of Treatment With Erlotinib#898844ClinicalTrials.gov
• Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon#1045048ClinicalTrials.gov
• The Early Response After Radiation Therapy on Three-Dimensional Oral Cancer Model Using Patient-Derived Cancer-Associated Fibroblasts#355162OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY